Astera Labs (NASDAQ:ALAB) Stock Price Up 3.3% - Still a Buy?

Key Points

• Astera Labs shares rose 3.3% to about $303.25 on heavier-than-average trading volume, giving the company a market capitalization of approximately $52.6 billion.
• Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus and an average price target of $348.33; individual targets range as high as $460.
• The company exceeded quarterly expectations, reporting $0.80 EPS and $392.4 million in revenue, up 104.5% year over year. However, its valuation is elevated at a P/E ratio of about 150, while insiders have sold roughly $209.7 million of stock over the past three months.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares traded up 3.3% during trading on Friday . The stock traded as high as $303.95 and last traded at $303.25. Approximately 7,015,461 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 5,260,806 shares. The stock had previously closed at $293.56.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a report on Monday, July 20th. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a report on Wednesday, June 24th. Needham & Company LLC boosted their price target on Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Citigroup restated a "buy" rating on shares of Astera Labs in a research note on Wednesday, July 29th. Finally, Zacks Research raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Astera Labs presently has an average rating of "Moderate Buy" and an average target price of $348.33.

Astera Labs Trading Up 3.3%

The company's 50-day moving average price is $305.52 and its two-hundred day moving average price is $265.13. The company has a market cap of $52.61 billion, a P/E ratio of 150.12 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the company posted $0.44 EPS. Astera Labs's revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 6,801 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company's stock, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares of the company's stock, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 592,244 shares of company stock worth $209,729,973. 10.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently made changes to their positions in the business. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs in the 2nd quarter valued at $25,000. Archer Investment Corp bought a new position in shares of Astera Labs during the 2nd quarter worth approximately $30,000. Transamerica Financial Advisors LLC acquired a new stake in Astera Labs in the 2nd quarter valued at $35,000. Continuum Advisory LLC bought a new stake in Astera Labs in the second quarter valued at $37,000. Finally, Johnson Financial Group Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth about $43,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company's portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.